Christine M. Lovly, MD, PhD
机构: Associate Professor of Medicine, Vanderbilt University Medical Center
每年引用次数
引用次数
引用: 53,403
H-指数: 120
I10-指数 : 591
出版物: 1,408
A Review of Immunotherapy for Stage III and Metastatic Non-Small Cell Lung Cancer and the Rationale for the ECOG-ACRIN EA5181 Study.
Heather Wakelee , Maximilian Diehn , Chandra Belani , Nathan A. Pennell
Oncologist 26 ( 6) 523 -532
2021
The role of NF-κB-1 and NF-κB-2-mediated resistance to apoptosis in lymphomas
L. Bernal-Mizrachi , C. M. Lovly , L. Ratner
Proceedings of the National Academy of Sciences of the United States of America 103 ( 24) 9220 -9225
91
2006
Translating genomic information into clinical medicine: Lung cancer as a paradigm
M. A. Levy , C. M. Lovly , W. Pao
Genome Research 22 ( 11) 2101 -2108
60
2012
Escaping ALK Inhibition: Mechanisms of and Strategies to Overcome Resistance
C. M. Lovly , W. Pao
Science Translational Medicine 4 ( 120)
86
2012
Characterization of novel potent and selective anaplastic lymphoma kinase (ALK) inhibitors.
C. M. Lovly , E. de Stanchina , H. Chen , C. Liang
Journal of Clinical Oncology 29
1
2011
My Cancer Genome: Web-based clinical decision support for genome-directed lung cancer treatment.
M. A. Levy , C. M. Lovly , L. Horn , R. Naser
Journal of Clinical Oncology 29 7576 -7576
10
2011
DIRECT: DNA-mutation Inventory to Refine and Enhance Cancer Treatment—A catalogue of clinically relevant somatic mutations in lung cancer.
L. Horn , H. Chen , C. M. Lovly , J. Andrews
Journal of Clinical Oncology 29 7575 -7575
9
2011
Unique HIV type 1 V3 region sequences derived from six different regions of brain: region-specific evolution within host-determined quasispecies.
JOON CHANG , RAFAEL JOZWIAK , BIN WANG , THOMAS NG
AIDS Research and Human Retroviruses 14 ( 1) 25 -30
75
1998
Fragments of ATM which have dominant-negative or complementing activity.
S E Morgan , C Lovly , T K Pandita , Y Shiloh
Molecular and Cellular Biology 17 ( 4) 2020 -2029
155
1997
Genomic profiling of 114,200 advanced cancers identifies recurrent kinase domain duplications (KDD) and oncogenic rearrangements (RE) across diverse tumor types
LM Gay , D Pavlick , J Chung , S Ramkissoon
Annals of Oncology 28 v595 -v595
6
2017
Comprehensive genomic profiling (CGP) of 114,200 advanced cancers identifies recurrent kinase domain duplications (KDD) and novel oncogenic fusions in diverse tumor types
S Ikeda , L Gay , D Pavlick , J Chung
Annals of Oncology 28 x1 -x1
3
2017
P50. 01 RELAY, Erlotinib Plus Ramucirumab in Untreated, EGFR-Mutated, Metastatic NSCLC: Outcomes by EGFR Exon 19-del Variants
K Nishino , J Shih , C Lovly , K Nakagawa
Journal of Thoracic Oncology 16 ( 10) S1114 -S1115
2021
Immunohistochemical Analysis of ALK Fusion-Positive Lung Cancers: Correlation with FISH, Molecular Findings and Morphology
ST Saab , C Lovly , CJ Hollis , Y Ashwini
LABORATORY INVESTIGATION 91 423A -423A
1
2011
Anaplastic lymphoma kinase (ALK) fusion oncogene positive non-small cell lung cancer
Benjamin Solomon , C Lovly
Uptodate. Waltham, MA: UpToDate. Accessed July 5
5
2020
Implications of selection bias due to delayed study entry in clinical genomic studies
Samantha Brown , Jessica A Lavery , Ronglai Shen , Axel S Martin
JAMA oncology 8 ( 2) 287 -291
31
2022
Correlation between surrogate end points and overall survival in a multi-institutional clinicogenomic cohort of patients with non–small cell lung or colorectal cancer
Kenneth L Kehl , Gregory J Riely , Eva M Lepisto , Jessica A Lavery
JAMA Network Open 4 ( 7) e2117547 -e2117547
19
2021
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016
Andreas Lundqvist , Vincent van Hoef , Xiaonan Zhang , Erik Wennerberg
Journal for immunotherapy of cancer 4 1 -106
10
2016
Pilot Projects
Lead By Dr Chrisitne Lovly , Prasad Kopparapu
Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding
Paul R Graves , Christine M Lovly , Geoffrey L Uy , Helen Piwnica-Worms
Oncogene 20 ( 15) 1839 -1851
181
2001
Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancer
Christine M Lovly , Nerina T McDonald , Heidi Chen , Sandra Ortiz-Cuaran
Nature Medicine 20 ( 9) 1027 -1034
262
2014
Leora Horn Wade Iams William Pao Heather Wakelee Ross Camidge David P Carbone Edward Garon Douglas B Johnson Pierre Massion Yu Shyr Gregory J. Riely, MD, PhD Robert C. Doebele, MD, PhD Geoffrey R. Oxnard, MD Helena Yu Siraj Ali Sai-Hong Ignatius Ou Justin M. Balko Alexa Schrock Igor Puzanov Justin Gainor